Diabetes mellitus (DM) is a common multifactorial disease, causing various complications,
such as chronic metabolism. The current therapies for diabetes mellitus are commercial …

Probiotics are essential to improve the health of the host, whereas maintaining the viability of
probiotics in harsh environments remains a challenge. Polysaccharides have non-toxicity …

Protein and peptide drugs are predominantly administered by injection to achieve high
bioavailability, but this greatly compromises patient compliance. Oral and transdermal drug …

The oral route has long been recognized as the most preferred route for drug delivery as it
offers high patient compliance and requires minimal expertise. Unlike small molecule drugs …

In recent years, natural polysaccharides have been considered as the ideal candidates for
novel drug delivery systems because of their good biocompatibility, biodegradation, low …

Diabetes mellitus is a prevalent metabolic and endocrine illness affecting people all over the
world and is of serious health and financial concern. Antidiabetic medicine delivered …

Diabetes mellitus (DM) is a global health threat. Searching for anti-diabetic components from
natural resources is of intense interest to scientists. Mushroom polysaccharides have …

Cancer is the second most common cause of death globally, surpassed only by
cardiovascular disease. One of the hallmarks of cancer is uncontrolled cell division and …

Diabetes mellitus is a chronic metabolic disease that affects> 500 million patients worldwide.
Subcutaneous injection of insulin is the most effective treatment at present. However, regular …

In order to improve bioavailability, stability, control release, and target delivery of active
pharmaceutical ingredients (APIs), as well as to mask their bitter taste, to increase their …